MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $3.4M of Moderna, Inc.
Sold$3,356,761
$167.84Price
20,000Shares
What MRNA did after the filing
- The stock from Mon, Feb 13 open, $168.73
- −12.9%
- S&P 500, same days
- −2.8%
Measured over 30 trading days, to the Mar 28 close.
Traded Wed, Feb 8. Filed Fri, Feb 10, 7:30 PM ET, after the close. Returns use the Feb 13 open and the Mar 28 close. Not investment advice.